Whitmore Limited and Chengming Tang
Filed with the SEC on · accession 0001213900-26-096331
UPC filed a SCHEDULE 13G (schedule 13g) with the SEC on Sep 1, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -6.8% by the first close after the filing.
Whitmore Limited and Chengming Tang filed a joint filing agreement under Schedule 13G regarding their ownership of Class A ordinary shares of Universe Pharmaceuticals INC.
Close before
$4.58
Aug 31, 2026
First close after
-6.77%
$4.27
5 trading days
-8.30%
$4.20
Since filing
-69.65%
$1.39
✦ Ask GOAX AI about this filing — what it means for UPC, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for UPC?
Click hereUPC filed a SCHEDULE 13G (SEC filing). Whitmore Limited and Chengming Tang filed a joint filing agreement under Schedule 13G regarding their ownership of Class A ordinary shares of Universe Pharmaceuticals INC.
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
UPC closed at $4.58 before the filing and $4.27 on Sep 1, 2026 (-6.77%). Five trading days later: $4.20 (-8.30%).
Get alerts when UPC files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days